Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Filippo Lagi and Matteo Piccica.
Filippo Lagi
Connection Strength
0.860
Matteo Piccica
  1. Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy. Int J Infect Dis. 2021 Jul; 108:231-236.
    View in: PubMed
    Score: 0.235
  2. High-dose steroids for the treatment of severe COVID-19. Intern Emerg Med. 2021 08; 16(5):1395-1399.
    View in: PubMed
    Score: 0.235
  3. Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020. Euro Surveill. 2020 04; 25(17).
    View in: PubMed
    Score: 0.219
  4. The prognostic role of IL-10 in non-severe COVID-19 with chemosensory dysfunction. Cytokine. 2021 05; 141:155456.
    View in: PubMed
    Score: 0.058
  5. Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19. Allergy Rhinol (Providence). 2020 Jan-Dec; 11:2152656720968804.
    View in: PubMed
    Score: 0.057
  6. Cancer population may be paradoxically protected from severe manifestations of COVID-19. J Infect. 2020 08; 81(2):e156-e158.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.